These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9099992)

  • 1. Protein kinase A-dependent activation of PDE4 (cAMP-specific cyclic nucleotide phosphodiesterase) in cultured bovine vascular smooth muscle cells.
    Ekholm D; Belfrage P; Manganiello V; Degerman E
    Biochim Biophys Acta; 1997 Mar; 1356(1):64-70. PubMed ID: 9099992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo.
    Tilley DG; Maurice DH
    Mol Pharmacol; 2002 Sep; 62(3):497-506. PubMed ID: 12181425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors: role of protein kinase A in vascular smooth muscle cell mitogenesis.
    Osinski MT; Schrör K
    Biochem Pharmacol; 2000 Aug; 60(3):381-7. PubMed ID: 10856433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of phosphodiesterase IV during desensitization of the A2A adenosine receptor-mediated cyclic AMP response in rat pheochromocytoma (PC12) cells.
    Chang YH; Conti M; Lee YC; Lai HL; Ching YH; Chern Y
    J Neurochem; 1997 Sep; 69(3):1300-9. PubMed ID: 9282956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors.
    Palmer D; Tsoi K; Maurice DH
    Circ Res; 1998 May; 82(8):852-61. PubMed ID: 9576105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phorbol 12-myristate 13-acetate triggers the protein kinase A-mediated phosphorylation and activation of the PDE4D5 cAMP phosphodiesterase in human aortic smooth muscle cells through a route involving extracellular signal regulated kinase (ERK).
    Baillie G; MacKenzie SJ; Houslay MD
    Mol Pharmacol; 2001 Nov; 60(5):1100-11. PubMed ID: 11641439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
    Rose RJ; Liu H; Palmer D; Maurice DH
    Br J Pharmacol; 1997 Sep; 122(2):233-40. PubMed ID: 9313930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
    Erdogan S; Houslay MD
    Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation and induction of cyclic AMP phosphodiesterase (PDE4) in rat pulmonary microvascular endothelial cells.
    Zhu B; Kelly J; Vemavarapu L; Thompson WJ; Strada SJ
    Biochem Pharmacol; 2004 Aug; 68(3):479-91. PubMed ID: 15242814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase signaling pathways. A potential mechanism allowing for the coordinated regulation of PDE4D activity and expression in cells.
    Liu H; Palmer D; Jimmo SL; Tilley DG; Dunkerley HA; Pang SC; Maurice DH
    J Biol Chem; 2000 Aug; 275(34):26615-24. PubMed ID: 10851231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1).
    MacKenzie SJ; Baillie GS; McPhee I; MacKenzie C; Seamons R; McSorley T; Millen J; Beard MB; van Heeke G; Houslay MD
    Br J Pharmacol; 2002 Jun; 136(3):421-33. PubMed ID: 12023945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
    Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
    Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced remodelling of PDE4 isoform expression and cAMP handling in human pulmonary artery smooth muscle cells.
    Millen J; MacLean MR; Houslay MD
    Eur J Cell Biol; 2006 Jul; 85(7):679-91. PubMed ID: 16458997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.
    Murthy KS
    Biochem J; 2001 Nov; 360(Pt 1):199-208. PubMed ID: 11696008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation.
    Eckly-Michel A; Martin V; Lugnier C
    Br J Pharmacol; 1997 Sep; 122(1):158-64. PubMed ID: 9298542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol increases phosphodiesterase 4 activity in bovine bronchial epithelial cells.
    Forgèt MA; Sisson JH; Spurzem JR; Wyatt TA
    Alcohol; 2003; 31(1-2):31-8. PubMed ID: 14615009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adrenaline and glucocorticoids on monocyte cAMP-specific phosphodiesterase (PDE4) in a monocytic cell line.
    Delgado M; Fernández-Alfonso MS; Fuentes A
    Arch Dermatol Res; 2002 Jul; 294(4):190-7. PubMed ID: 12111350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of lipopolysaccharide-induced tumor necrosis factor-alpha generation from human peripheral blood monocytes by inhibitors of phosphodiesterase 4: interaction with stimulants of adenylyl cyclase.
    Seldon PM; Barnes PJ; Meja K; Giembycz MA
    Mol Pharmacol; 1995 Oct; 48(4):747-57. PubMed ID: 7476903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipid regulation of a cyclic AMP-specific phosphodiesterase (PDE4) from U937 cells.
    DiSanto ME; Glaser KB; Heaslip RJ
    Cell Signal; 1995 Nov; 7(8):827-35. PubMed ID: 8593251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.